Previous bird flu outbreaks and decades-old public health infrastructure have led industry to protect the hens used for ...

Explore the evolution of vaccine technology from Jenner to mRNA, highlighting India's role in COVID-19 vaccine development.

The partnership comprises a technology transfer of the current drug product manufacturing process for the Chikungunya Vaccine ...

Biological E partners with Bavarian Nordic to expand access to Chikungunya Vaccine in low- and middle-income countries.

Hyderabad (Telangana) [India], February 25 (ANI): Biological E Limited (BE) on Tuesday announced a strategic partnership with ...

The World Health Organization (WHO) today announced the recommendations for the viral composition of influenza vaccines for ...

The global mammalian transient protein expression market is on a robust growth trajectory, projected to reach USD 762.34 million in 2024 and expand at a CAGR of 5.5% over the next decade, ultimately ...

This partnership comprises a technology transfer of the current drug product manufacturing process for the Chikungunya ...

Hyderabad-based Biological E. Limited (BE) is partnering with Danish firm Bavarian Nordic to expand access to the latter’s ...

First chikungunya vaccine approved in Europe for persons as young as 12 years old. On track for launch in key European ...